180 related articles for article (PubMed ID: 9088587)
1. Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects.
Spina E; Avenoso A; Campo GM; Scordo MG; Caputi AP; Perucca E
Br J Clin Pharmacol; 1997 Mar; 43(3):315-8. PubMed ID: 9088587
[TBL] [Abstract][Full Text] [Related]
2. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects.
Spina E; Pollicino AM; Avenoso A; Campo GM; Perucca E; Caputi AP
Ther Drug Monit; 1993 Jun; 15(3):243-6. PubMed ID: 8333005
[TBL] [Abstract][Full Text] [Related]
3. Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction.
Bergstrom RF; Peyton AL; Lemberger L
Clin Pharmacol Ther; 1992 Mar; 51(3):239-48. PubMed ID: 1544284
[TBL] [Abstract][Full Text] [Related]
4. The effect of sertraline on the pharmacokinetics of desipramine and imipramine.
Kurtz DL; Bergstrom RF; Goldberg MJ; Cerimele BJ
Clin Pharmacol Ther; 1997 Aug; 62(2):145-56. PubMed ID: 9284850
[TBL] [Abstract][Full Text] [Related]
5. Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies.
Venkatakrishnan K; Schmider J; Harmatz JS; Ehrenberg BL; von Moltke LL; Graf JA; Mertzanis P; Corbett KE; Rodriguez MC; Shader RI; Greenblatt DJ
J Clin Pharmacol; 2001 Oct; 41(10):1043-54. PubMed ID: 11583471
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin.
Böttiger Y; Tybring G; Götharson E; Bertilsson L
Clin Pharmacol Ther; 1997 Oct; 62(4):384-91. PubMed ID: 9357389
[TBL] [Abstract][Full Text] [Related]
7. Effect of troleandomycin on the pharmacokinetics of imipramine in Chinese: the role of CYP3A.
Wang JS; Wang W; Xie HG; Huang SL; Zhou HH
Br J Clin Pharmacol; 1997 Aug; 44(2):195-8. PubMed ID: 9278210
[TBL] [Abstract][Full Text] [Related]
8. Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4.
Madsen H; Rasmussen BB; Brøsen K
Clin Pharmacol Ther; 1997 Mar; 61(3):319-24. PubMed ID: 9084457
[TBL] [Abstract][Full Text] [Related]
9. Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity.
Brynne N; Forslund C; Hallén B; Gustafsson LL; Bertilsson L
Br J Clin Pharmacol; 1999 Oct; 48(4):564-72. PubMed ID: 10583027
[TBL] [Abstract][Full Text] [Related]
10. Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine.
Brøsen K; Gram LF
Eur J Clin Pharmacol; 1989; 37(2):155-60. PubMed ID: 2792169
[TBL] [Abstract][Full Text] [Related]
11. Imipramine metabolism in relation to the sparteine and mephenytoin oxidation polymorphisms--a population study.
Madsen H; Nielsen KK; Brøsen K
Br J Clin Pharmacol; 1995 Apr; 39(4):433-9. PubMed ID: 7640151
[TBL] [Abstract][Full Text] [Related]
12. Phenobarbital induces the 2-hydroxylation of desipramine.
Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
Ther Drug Monit; 1996 Feb; 18(1):60-4. PubMed ID: 8848823
[TBL] [Abstract][Full Text] [Related]
13. Effect of venlafaxine on imipramine metabolism.
Albers LJ; Reist C; Vu RL; Fujimoto K; Ozdemir V; Helmeste D; Poland R; Tang SW
Psychiatry Res; 2000 Nov; 96(3):235-43. PubMed ID: 11084219
[TBL] [Abstract][Full Text] [Related]
14. The Use of In Vitro Data and Physiologically-Based Pharmacokinetic Modeling to Predict Drug Metabolite Exposure: Desipramine Exposure in Cytochrome P4502D6 Extensive and Poor Metabolizers Following Administration of Imipramine.
Nguyen HQ; Callegari E; Obach RS
Drug Metab Dispos; 2016 Oct; 44(10):1569-78. PubMed ID: 27440861
[TBL] [Abstract][Full Text] [Related]
15. The role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation.
Chiba K; Saitoh A; Koyama E; Tani M; Hayashi M; Ishizaki T
Br J Clin Pharmacol; 1994 Mar; 37(3):237-42. PubMed ID: 8198931
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole.
Harris RZ; Salfi M; Sullivan JT; Padhi D
Clin Pharmacokinet; 2007; 46(6):495-501. PubMed ID: 17518508
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of imipramine N-demethylation by fluvoxamine in Chinese young men.
Xu ZH; Huang SL; Zhou HH
Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):399-402. PubMed ID: 9863158
[TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability of imipramine (Tofranil) coated tablets in healthy volunteers.
Ullmann U; Lehnfeld R; Bliesath H; Birkel M; Gebbing H; Gräve M; Wolf H
Int J Clin Pharmacol Ther; 2001 Jun; 39(6):271-6. PubMed ID: 11430636
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin.
Kerbusch T; Jansen RL; Mathôt RA; Huitema AD; Jansen M; van Rijswijk RE; Beijnen JH
Clin Pharmacol Ther; 2001 Aug; 70(2):132-41. PubMed ID: 11503007
[TBL] [Abstract][Full Text] [Related]
20. Isolation of partially purified P450 2D18 and characterization of activity toward the tricyclic antidepressants imipramine and desipramine.
Thompson CM; Kawashima H; Strobel HW
Arch Biochem Biophys; 1998 Nov; 359(1):115-21. PubMed ID: 9799568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]